Severe cases may progress to increased brain pressure, which represents a life-threatening complication requiring emergency intervention
Barriers to initiating treatment may include delayed recognition of obesity as a disease by public health and medical organizations, provider biases regarding patients with obesity, lack of reimbursement leading to out-of-pocket costs to patients, inadequate training of providers, historical safety issues with AOMs, and perceptions of patients and their caregivers regarding the efficacy of AOMs [14,15,16,17]
Any use outside structured laboratory researchincluding administration to humans or animalsis strictly prohibited
For readers who want to understand medication support during treatment, what GLP-1 support can do for your weight loss journey can be a useful companion read
We follow up regularly to monitor healing, fine-tune your plan, and empower you with the knowledge to prevent recurrence